Registry of Lobbyists

Monthly Communication Report

Return to 12-Month Lobbying Summary - Innovative Medicines Canada / Médicaments novateurs Canada

369075-587216

Corporation: Wal-Mart Canada Corp./La Compagnie Wal-Mart du Canada
Associated registration: 954042-369075-13
Communication date: 2023-11-20
Posted date: 2023-12-14

Designated Public Office Holders who participated in the communication: Iqwinder Gaheer, Member of Parliament
House of Commons
 
Subject Matter of the communication: Justice and Law Enforcement,  Privacy and Access to Information Footnote1
 
Responsible Officer who filed this communication report: Gonzalo Gebara
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 
 
  1. Footnote1  Indicates new information that was added through a monthly communications return.
 

Return to 12-Month Lobbying Summary - Innovative Medicines Canada / Médicaments novateurs Canada
Date Modified: